// App-Quantinova.ai

3400 : An angiogenesis gene signature points to active TGF-beta/JAK signaling pathways in a subset of human pancreatic ductal adenocarcinoma cancer patients that are distinct from pathways in pancreatic neuroendocrine tumors

Researchers

Presenter

  • Kelly E. Craven

Principal Investigators

  • Jesse Gore

  • Julie L. Wilson

  • Murray Korc

Medical Centers

  • Indiana University School of Medicine, Indianapolis, IN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic Neuroendocrine Tumors

  • Neuroendocrine tumors

  • Pancreatic cancer

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Janus kinase

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A